Charles River Laboratories International

Bookmark

Add to MyYahoo RSS

Charles River Laboratories International News

News on Charles River Laboratories International (Ticker: CRL) continually updated from thousands of sources around the net.

3 hrs ago | Drug Researcher

Harlan looks to corner NCI grantees lost by Charles River

News of the discontinuation of the National Cancer Institute's Animal Production Program has led Charles River Laboratories rival Harlan to vie for the market of grantees that still need animal research models.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Frederick, MD, Marketing

Tue Aug 19, 2014

AmericanBankingNews.com

Insider Selling: Charles River Laboratories CFO Sells 23,156 Shares of Stock

Charles River Laboratories CFO Thomas F. Ackerman sold 23,156 shares of the company's stock in a transaction dated Monday, August 18th.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Thu Aug 14, 2014

Hispanic Business

Charles River Laboratories Announces Second-Quarter 2014 Results from Continuing Operations

On a non-GAAP basis, second-quarter revenue increased 15.9%. The acquisition of Argenta and , contributed 8.0% to second-quarter revenue, and foreign currency translation benefited reported revenue by 1.4%.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Wed Aug 13, 2014

AmericanBankingNews.com

Charles River Laboratories Rating Reiterated by Deutsche Bank

's stock had its "hold" rating reiterated by investment analysts at Deutsche Bank in a note issued to investors on Wednesday.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Mon Aug 11, 2014

Drug Researcher

CRL nears 85% capacity use, but says sector pricing won't improve yet

Charles River Laboratories is approaching its optimal capacity utilisation but says pricing will not improve until the rest of the preclinical CRO industry follows suit.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Pharmacology

Seeking Alpha

Parexel - Best CRO, But Wait For A Better Moment

In my last article , I talked about the 3 major trends expected to affect the near future in the healthcare sector.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Fri Aug 08, 2014

AmericanBankingNews.com

Charles River Laboratories Receives Neutral Rating from Credit Suisse

's stock had its "neutral" rating reiterated by research analysts at Credit Suisse in a report released on Friday.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Stanley

BioSpace

Galapagos NV Cash Position Of ???232 M Provides Solid Basis For R&D Pipeline Investment

Net profit of 56 M for first half 2014 - Solid cash balance of 232 M on 30 June 2014, liquid assets position of 240 M - Group revenues 63 M, including 18 M revenues from discontinued service operations - Operating loss of continuing operations 15 M, reflecting planned increase in pipeline investment - Group net profit 56 M, resulting from 68 M net ... (more)

Comment?

Related Topix: World News, Ecuador, Belgium, Biotech, Medicine, Healthcare Industry, Crohn's Disease, Health

Thu Aug 07, 2014

Seeking Alpha

Charles River Laboratories International's (CRL) CEO James Foster on...

James C. Foster - Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Strategic Planning & Capital Allocation Committee Ladies and gentlemen, thank you for standing by.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Charles River Laboratories International

Wed Aug 06, 2014

Freshnews

Charles River Laboratories Announces Second-Quarter 2014 Results from Continuing Operations

Charles River Laboratories International, Inc. today reported its results for the second quarter of 2014.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Thu Jul 24, 2014

Freshnews

Charles River Laboratories to Webcast Investor Meeting

Charles River Laboratories International, Inc. announced today that it will hold a meeting for the investment community with its management team on Tuesday, August 12, 2014 in New York.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Business Wire

Press release distribution, EDGAR filing, XBRL, regulatory filings

Regions Bank Expands Multifamily Real Estate Banking Capabilities by Obtaining Fannie Mae Delegated Underwriting and Servicing Approval and $1 Billion Servicing Portfolio )--Regions Bank, the primary banking subsidiary of Regions Financial Corporation , today announced that it has been approved as a Fannie Mae Delegated Under... )--SimCorp ... (more)

Comment?

Related Topix: Marketing, Biotech, Medicine, Healthcare Industry

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••